VENOM

VENOM is a brokerage company registered in the United States, established on August 5, 2021. According to its registration records, the firm is located at 3008 E. Hebron Pkwy, Building 400, Carrollton, TX 75010. The company describes itself as a provider of trading services across multiple asset classes, including stocks, options, futures, and forex.

Despite being registered in the US, VENOM does not hold any known regulatory licences. This absence of oversight is a significant factor for traders to consider, as it means the broker is not subject to the investor protection frameworks common among regulated brokers.

Based on the available information, VENOM offers trading in stocks, options, futures, and forex. The company claims to provide a trading platform with no software fees, targeting clients with a minimum account size of $5,000. It also offers a demo version of its desktop platform for prospective clients to test.

The fee structure, as stated by the firm, includes stock commissions of $0.004 per share with a $1 minimum, options at $0.75 per contract, futures at $1.25 per side, and forex at 0.20 basis points per transaction value with a minimum charge. These details come from the company's description, but independent verification is limited due to the lack of official website access.

The broker mentions a $5,000 minimum account requirement, which positions it as catering to more serious retail or experienced traders. It also references a 'Venom Desktop' demo, suggesting a proprietary trading platform, though no further details on platform features or additional account tiers are available.

Without access to the official website or live trading environment, it is not possible to confirm the full range of account types, supported operating systems, or mobile trading options. The social media presence on Facebook, Instagram, LinkedIn, and YouTube indicates some level of brand activity, but the content and engagement cannot be assessed.

VENOM has no known regulatory licence from any financial authority. This is a critical point, as unregulated brokers offer no recourse to external dispute resolution or compensation schemes. Traders would have limited protection if issues arise regarding fund safety, execution, or withdrawal.

The FXCanary Scam Risk Score of 43/100 ('Guarded') reflects this regulatory gap and the general lack of transparent, independently verifiable information about the broker's operations. The company's US registration alone does not equate to regulatory oversight by agencies such as the SEC or CFTC.

Our review finds that public information about VENOM is extremely sparse. The official domain listed is 'clientam.com', but this domain appears to be associated with Interactive Brokers, not VENOM. This discrepancy raises concerns about whether the broker's online presence is properly established or if the domain is shared.

Given the lack of a verifiable website, clear licensing, and independent reviews, traders should approach VENOM with considerable caution. The absence of reliable information is itself a warning signal for any potential client.